Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Accuracy and Potential Benefit of Ultraselective Invasive Coronary Angiography Guided by Computed Tomographic Coronary Angiography

Autor: Beek, K.A.J. van, Lepper, A.G.W. de, Veer, M. Van't, Bouwmeester, S., Otterspoor, L.C., Tonino, P.A.L., Lammers, J., Winkens, Mark, Nunen, L.X. van

Publikováno v: Journal of Invasive Cardiology, 34, E390-e396
Journal of Invasive Cardiology, 34, 5, pp. E390-e396

Item does not contain fulltext OBJECTIVES: It is unknown whether computed tomographic coronary angiography (CTCA) can be used to perform ultraselective invasive coronary angiography (ICA) by only visualizing the abnormal coronary artery on CTCA and d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::1acd6c9ff715c7cf84f6c7d6ce3a45d4
https://hdl.handle.net/2066/252224

Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ('ugly') locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT)

Autor: van den Berg, K., Schaap, D. P., Voogt, E. L. K., Buffart, T. E., Verheul, H. M. W., de Groot, J. W. B., Verhoef, C., Melenhorst, J., Roodhart, J. M. L., de Wilt, J. H. W., van Westreenen, H. L., Aalbers, A. G. J., van 't Veer, M., Marijnen, C. A. M., Vincent, J., Simkens, L. H. J., Peters, N. A. J. B., Berbée, M., Werter, I. M., Snaebjornsson, P., Peulen, H. M. U., van Lijnschoten, I. G., Roef, M. J., Nieuwenhuijzen, G. A. P., Bloemen, J. G., Willems, J. M. W. E., Creemers, G. J. M., Nederend, J., Rutten, H. J. T., Burger, J. W. A.

Publikováno v: BMC Cancer, 22(1):957. BioMed Central Ltd
BMC Cancer, 22(1):957. BioMed Central
BMC Cancer, 22
BMC Cancer, 22(1):957. BioMed Central Ltd.
BMC Cancer, 22, 1
van den Berg, K, Schaap, D P, Voogt, E L K, Buffart, T E, Verheul, H M W, de Groot, J W B, Verhoef, C, Melenhorst, J, Roodhart, J M L, de Wilt, J H W, van Westreenen, H L, Aalbers, A G J, van 't Veer, M, Marijnen, C A M, Vincent, J, Simkens, L H J, Peters, N A J B, Berbée, M, Werter, I M, Snaebjornsson, P, Peulen, H M U, van Lijnschoten, I G, Roef, M J, Nieuwenhuijzen, G A P, Bloemen, J G, Willems, J M W E, Creemers, G J M, Nederend, J, Rutten, H J T & Burger, J W A 2022, ' Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer : study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT) ', BMC Cancer, vol. 22, no. 1, 957, pp. 957 . https://doi.org/10.1186/s12885-022-09947-w

Background The presence of mesorectal fascia (MRF) invasion, grade 4 extramural venous invasion (EMVI), tumour deposits (TD) or extensive or bilateral extramesorectal (lateral) lymph nodes (LLN) on MRI has been suggested to identify patients with ind

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5e5e66763b1aab2bcbd20c945d69797
https://doi.org/10.1186/s12885-022-09947-w

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.